Polymorphisms in the Annexin gene family and the risk of osteonecrosis of the femoral head in the Korean population

Bone

Volumn 45, Issue 1, 2009, Pages 125-131

  Kim, Tae Ho ^a,b   Hong, Jung Min ^a   Shin, Eun Soon ^e   Kim, Hyun Ju ^a   Cho, Yoon Shin ^d   Lee, Jong Young ^d   Lee, Sang Han ^c   Park, Eui Kyun ^a,c   Kim, Shin Yoon ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

^d Korea National Institute of Health   (South Korea)

^e DNA Link Inc   (South Korea)

Author keywords

Annexin (ANX); Bone; Ca2+ homeostasis; Femoral head; Osteonecrosis; Single nucleotide polymorphism (SNP)

Indexed keywords

ANNEXIN; ANNEXIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMUR HEAD NECROSIS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANNEXIN A5; ANNEXIN A6; ANNEXINS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; FEMUR HEAD NECROSIS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67349149587     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.03.670     Document Type: Article

References (45)

1. Atsumi T., and Kuroki Y. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin. Orthop. Relat. Res. 277 (1992) 22-30
2. Assouline-Dayan Y., Chang C., Greenspan A., Shoenfeld Y., and Gershwin M.E. Pathogenesis and natural history of osteonecrosis. Semin. Arthritis Rheum. 32 (2002) 94-124
3. Fisher D.E. The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin. Orthop. Relat. Res. 130 (1978) 68-80
4. Wang Y., Li Y., Mao K., Li J., Cui Q., and Wang G.J. Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin. Orthop. Relat. Res. 410 (2003) 213-224
5. Jones L.C., Mont M.A., Le T.B., Petri M., Hungerford D.S., Wang P., et al. Procoagulants and osteonecrosis. J. Rheumatol. 30 (2003) 783-791
6. Abu-Shakra M., Buskila D., and Shoenfeld Y. Osteonecrosis in patients with SLE. Clin. Rev. Allergy Immunol. 25 (2003) 13-24
7. Hirota Y., Hirohata T., Fukuda K., Mori M., Yanagawa H., Ohno Y., et al. Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. Am. J. Epidemiol. 137 (1993) 530-538
8. Jones Jr. J.P. Intravascular coagulation and osteonecrosis. Clin. Orthop. Relat. Res. 277 (1992) 41-53
9. Gohel A., McCarthy M.B., and Gronowicz G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140 (1999) 5339-5347
10. Kawai K., Tamaki A., and Hirohata K. Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. J. Bone Joint Surg. Am. 67 (1985) 755-763
11. Calder J.D., Buttery L., Revell P.A., Pearse M., and Polak J.M. Apoptosis-a significant cause of bone cell death in osteonecrosis of the femoral head. J. Bone Joint Surg. Br. 86 (2004) 1209-1213
12. Lee J.S., Lee J.S., Roh H.L., Kim C.H., Jung J.S., and Suh K.T. Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J. Orthop. Res. 24 (2006) 604-609
13. Liemann S., and Lewit-Bentley A. Annexins: a novel family of calcium- and membrane-binding proteins in search of a function. Structure 3 (1995) 233-237
14. Reutelingsperger C.P., and van Heerde W.L. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell. Mol. Life Sci. 53 (1997) 527-532
15. Yoshizaki H., Tanabe S., Arai K., Murakami A., Wada Y., Ohkuchi M., et al. Effects of calphobindin II (annexin VI) on procoagulant and anticoagulant activities of cultured endothelial cells. Chem. Pharm. Bull. (Tokyo) 40 (1992) 1860-1863
16. Gerke V., and Moss S.E. Annexins and membrane dynamics. Biochim. Biophys. Acta 1357 (1997) 129-154
17. Xiao Z., Camalier C.E., Nagashima K., Chan K.C., Lucas D.A., de la Cruz M.J., et al. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts. J. Cell. Physiol. 210 (2007) 325-335
18. Balcerzak M., Malinowska A., Thouverey C., Sekrecka A., Dadlez M., Buchet R., et al. Proteome analysis of matrix vesicles isolated from femurs of chicken embryo. Proteomics 8 (2008) 192-205
19. Anderson H.C. Molecular biology of matrix vesicles. Clin. Orthop. Relat. Res. 314 (1995) 266-280
20. Baldwin C., Nolan V.G., Wyszynski D.F., Ma Q.L., Sebastiani P., Embury S.H., et al. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 106 (2005) 372-375
21. Reutelingsperger C.P., Hornstra G., and Hemker H.C. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur. J. Biochem. 151 (1985) 625-629
22. Vora S., Ghosh K., Shetty S., Salvi V., and Satoskar P. Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India. Thromb. J. 5 (2007) 9
23. Kim T.H., Hong J.M., Park E.K., and Kim S.Y. Peroxisome proliferator-activated receptor-gamma gene polymorphisms are not associated with osteonecrosis of the femoral head in the Korean population. Mol. Cells 24 (2007) 388-393
24. Hardenbol P., Yu F., Belmont J., Mackenzie J., Bruckner C., Brundage T., et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Res. 15 (2005) 269-275
25. Hedrick P.W. Gametic disequilibrium measures: proceed with caution. Genetics 117 (1987) 331-341
26. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
27. Lachin J.M. Introduction to sample size determination and power analysis for clinical trials. Control Clin. Trials 2 (1981) 93-113
28. Goldstein D.B. Islands of linkage disequilibrium. Nat. Genet. 29 (2001) 109-111
29. Cruess R. Osteonecrosis of bone: current concepts as to etiology and pathogenesis. Clin. Orthop. 208 (1986) 30-39
30. Glueck C.J., Freiberg R.A., and Wang P. Role of thrombosis in osteonecrosis. Curr. Hematol. Rep. 2 (2003) 417-422
31. Kerachian M., Harvey E., Cournoyer D., Chow T., and Seguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13 (2006) 237-244
32. Glueck C.J., Freiberg R., Tracy T., Stroop D., and Wang P. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin. Orthop. Relat. Res. 334 (1997) 43-56
33. Zalavras C.G., Malizos K.N., Dokou E., and Vartholomatos G. The 677C->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. Haematologica 87 (2002) 111-112
34. Zalavras C.G., Vartholomatos G., Dokou E., and Malizos K.N. Genetic background of osteonecrosis: associated with thrombophilic mutations?. Clin. Orthop. Relat. Res. 422 (2004) 251-255
35. Kim S.Y., Suh J.S., Park E.K., Jung W.B., Kim J.W., Koo K.H., et al. Factor V Leiden gene mutation in femoral head osteonecrosis. J. Korean Ortho. Res. Soc. 6 (2003) 259-264
36. Chang J.D., Hur M., Lee S.S., Yoo J.H., and Lee K.M. Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population. Clin. Orthop. Relat. Res. 466 (2008) 1041-1046
37. Glueck C.J., Freiberg R.A., Oghene J., Fontaine R.N., and Wang P. Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur. J. Bone Joint Surg. Am. 89 (2007) 2460-2468
38. Koo K.H., Lee J.S., Lee Y.J., Kim K.J., Yoo J.J., and Kim H.J. Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. J. Orthop. Res. 24 (2006) 1722-1728
39. Kim T.H., Hong J.M., Lee J.Y., Oh B., Park E.K., Lee C.K., et al. Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population. Osteoarthr. Cartil. 16 (2008) 287-291
40. Hong J.M., Kim T.H., Chae S.C., Koo K.H., Lee Y.J., Park E.K., et al. Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean population. Osteoarthr. Cartil. 15 (2007) 688-694
41. Anderson H.C. Matrix vesicles and calcification. Curr. Rheumatol. Rep. 5 (2003) 222-226
42. Monastyrskaya K., Tschumi F., Babiychuk E.B., Stroka D., and Draeger A. Annexins sense changes in intracellular pH during hypoxia. Biochem. J. 409 (2008) 65-75
43. Pfander D., Swoboda B., and Kirsch T. Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. Am. J. Pathol. 159 (2001) 1777-1783
44. Theobald J., Smith P.D., Jacob S.M., and Moss S.E. Expression of annexin VI in A431 carcinoma cells suppresses proliferation: a possible role for annexin VI in cell growth regulation. Biochim. Biophys. Acta 1223 (1994) 383-390
45. Ast G. How did alternative splicing evolve?. Nat. Rev., Genet 5 (2004) 773-782